Cite
MLA Citation
S.C. Kim et al.. “OP0002 No difference in the risk of malignancy in tocilizumab versus tnf inhibitor initiators in patients with rheumatoid arthritis: a multi-database cohort study.” Annals of the rheumatic diseases, vol. 77, n.d., p. 50. http://access.bl.uk/ark:/81055/vdc_100144730512.0x000053